Marc A. Becker, Chief Financial Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 2,875 shares at $10.24 ($29K) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Scheduled sale ($29k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNCE | SELL | 2023-01-09 | $21K | — | Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |